tiprankstipranks
Alibaba Health Information Technology Ltd. (CH:TWY)
:TWY
Switzerland Market

Alibaba Health Information Technology (TWY) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

TWY Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
7 Buy
1 Hold
2 Sell
Based on 10 analysts giving stock ratings to
Alibaba
Health Information Technology
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TWY Stock 12 Month Forecast

Average Price Target

CHF0.55
Based on 10 Wall Street analysts offering 12 month price targets for Alibaba Health Information Technology in the last 3 months. The average price target is CHF0.55 with a high forecast of CHF0.67 and a low forecast of CHF0.42. The average price target represents a change from the last price of .
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
Highest Price TargetCHF0.67Average Price TargetCHF0.55Lowest Price TargetCHF0.42
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:TWY
Jefferies
Jefferies
CHF0.55
Buy
Reiterated
05/19/26
Jefferies Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
Goldman Sachs Analyst forecast on CH:TWY
Goldman Sachs
Goldman Sachs
CHF0.5CHF0.43
Hold
Reiterated
05/19/26
Goldman Sachs Remains a Hold on Alibaba Health Information Technology (ALBHF)
Huatai Securities Analyst forecast on CH:TWY
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
CHF0.58CHF0.51
Buy
Reiterated
05/18/26
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on CH:TWY
Unknown Analyst
CICC
Not Ranked
CICC
CHF0.67
Buy
Reiterated
05/16/26
CICC Remains a Buy on Alibaba Health Information Technology (ALBHF)
Morgan Stanley Analyst forecast on CH:TWY
Morgan Stanley
Morgan Stanley
CHF0.43
Sell
Reiterated
05/15/26
Morgan Stanley’s Alexis Yan Reiterates Sell on Alibaba Health Amid Weak Earnings Momentum and High Upfront Investment Costs
Bank of America Securities Analyst forecast on CH:TWY
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
CHF0.62
Buy
Reiterated
04/14/26
Bank of America Securities Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UOB Kay Hian Analyst forecast on CH:TWY
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
CHF0.62
Buy
Reiterated
04/14/26
Alibaba Health Information Technology (ALBHF) Gets a Buy from UOB Kay Hian
GF Securities Analyst forecast on CH:TWY
Unknown Analyst
GF Securities
Not Ranked
GF Securities
CHF0.76CHF0.65
Buy
Reiterated
04/09/26
GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)
CLSA Analyst forecast on CH:TWY
Unknown Analyst
CLSA
Not Ranked
CLSA
CHF0.55
Buy
Reiterated
04/08/26
CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UBS Analyst forecast on CH:TWY
Unknown Analyst
UBS
Not Ranked
UBS
CHF0.42
Sell
Reiterated
04/07/26
UBS Remains a Sell on Alibaba Health Information Technology (ALBHF)
HSBC Analyst forecast on CH:TWY
Unknown Analyst
HSBC
Not Ranked
HSBC
CHF0.67
Hold
Reiterated
02/09/26
Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC
Citi Analyst forecast on CH:TWY
Unknown Analyst
Citi
Not Ranked
Citi
CHF0.93
Buy
Reiterated
02/05/26
Citi Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Citic Securities Analyst forecast on CH:TWY
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
CHF1.25
Buy
Reiterated
01/15/26
Guotai Haitong Analyst forecast on CH:TWY
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
CHF0.59
Buy
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
J.P. Morgan Analyst forecast on CH:TWY
J.P. Morgan
J.P. Morgan
CHF0.52CHF0.67
Hold
Reiterated
09/17/25
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. Morgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:TWY
Jefferies
Jefferies
CHF0.55
Buy
Reiterated
05/19/26
Jefferies Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
Goldman Sachs Analyst forecast on CH:TWY
Goldman Sachs
Goldman Sachs
CHF0.5CHF0.43
Hold
Reiterated
05/19/26
Goldman Sachs Remains a Hold on Alibaba Health Information Technology (ALBHF)
Huatai Securities Analyst forecast on CH:TWY
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
CHF0.58CHF0.51
Buy
Reiterated
05/18/26
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on CH:TWY
Unknown Analyst
CICC
Not Ranked
CICC
CHF0.67
Buy
Reiterated
05/16/26
CICC Remains a Buy on Alibaba Health Information Technology (ALBHF)
Morgan Stanley Analyst forecast on CH:TWY
Morgan Stanley
Morgan Stanley
CHF0.43
Sell
Reiterated
05/15/26
Morgan Stanley’s Alexis Yan Reiterates Sell on Alibaba Health Amid Weak Earnings Momentum and High Upfront Investment Costs
Bank of America Securities Analyst forecast on CH:TWY
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
CHF0.62
Buy
Reiterated
04/14/26
Bank of America Securities Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UOB Kay Hian Analyst forecast on CH:TWY
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
CHF0.62
Buy
Reiterated
04/14/26
Alibaba Health Information Technology (ALBHF) Gets a Buy from UOB Kay Hian
GF Securities Analyst forecast on CH:TWY
Unknown Analyst
GF Securities
Not Ranked
GF Securities
CHF0.76CHF0.65
Buy
Reiterated
04/09/26
GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)
CLSA Analyst forecast on CH:TWY
Unknown Analyst
CLSA
Not Ranked
CLSA
CHF0.55
Buy
Reiterated
04/08/26
CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UBS Analyst forecast on CH:TWY
Unknown Analyst
UBS
Not Ranked
UBS
CHF0.42
Sell
Reiterated
04/07/26
UBS Remains a Sell on Alibaba Health Information Technology (ALBHF)
HSBC Analyst forecast on CH:TWY
Unknown Analyst
HSBC
Not Ranked
HSBC
CHF0.67
Hold
Reiterated
02/09/26
Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC
Citi Analyst forecast on CH:TWY
Unknown Analyst
Citi
Not Ranked
Citi
CHF0.93
Buy
Reiterated
02/05/26
Citi Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Citic Securities Analyst forecast on CH:TWY
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
CHF1.25
Buy
Reiterated
01/15/26
Guotai Haitong Analyst forecast on CH:TWY
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
CHF0.59
Buy
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
J.P. Morgan Analyst forecast on CH:TWY
J.P. Morgan
J.P. Morgan
CHF0.52CHF0.67
Hold
Reiterated
09/17/25
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. Morgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alibaba Health Information Technology

3 Months
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+11.20%
Copying Alexis Yan's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +11.20% per trade.
1 Year
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+32.80%
Copying Alexis Yan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +32.80% per trade.
2 Years
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+32.80%
Copying Alexis Yan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +32.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TWY Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
1
1
0
1
1
Buy
3
2
7
7
7
Hold
2
1
2
2
2
Sell
1
0
1
2
2
Strong Sell
0
0
0
0
0
total
7
4
10
12
12
In the current month, TWY has received 8 Buy Ratings, 2 Hold Ratings, and 2 Sell Ratings. TWY average Analyst price target in the past 3 months is 0.55.
Each month's total comprises the sum of three months' worth of ratings.

TWY Financial Forecast

TWY Earnings Forecast

Next quarter’s earnings estimate for TWY is <CHF0.01 with a range of <CHF0.01 to <CHF0.01. The previous quarter’s EPS was <CHF0.01. TWY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year TWY has Performed in-line its overall industry.
Next quarter’s earnings estimate for TWY is <CHF0.01 with a range of <CHF0.01 to <CHF0.01. The previous quarter’s EPS was <CHF0.01. TWY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year TWY has Performed in-line its overall industry.

TWY Sales Forecast

Next quarter’s sales forecast for TWY is CHF2.19B with a range of CHF2.16B to CHF2.22B. The previous quarter’s sales results were CHF2.02B. TWY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year TWY has Performed in-line its overall industry.
Next quarter’s sales forecast for TWY is CHF2.19B with a range of CHF2.16B to CHF2.22B. The previous quarter’s sales results were CHF2.02B. TWY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year TWY has Performed in-line its overall industry.

TWY Stock Forecast FAQ

What is CH:TWY’s average 12-month price target, according to analysts?
Based on analyst ratings, Alibaba Health Information Technology Ltd.’s 12-month average price target is 0.55.
    What is CH:TWY’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:TWY, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Alibaba Health Information Technology Ltd. a Buy, Sell or Hold?
        Alibaba Health Information Technology Ltd. has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 1 hold ratings and 2 sell ratings.
          What is Alibaba Health Information Technology Ltd.’s share price target?
          The average share price target for Alibaba Health Information Technology Ltd. is 0.55. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF0.67 ,and the lowest forecast is CHF0.42. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Alibaba Health Information Technology Ltd.?
            Alibaba Health Information Technology Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
              How can I buy shares of Alibaba Health Information Technology Ltd.?
              To buy shares of CH:TWY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.